Taro Provides Results for the Quarter Ended June 30 2023

HAWTHORNE, N.Y.–(BUSINESS WIRE)– Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June 30, 2023. Quarter ended June 30, 2023 Highlights ─ compared to June 30, 2022 On June 29, 2023, Taro filed its Annual Report on Form 20-F with…Read More